Literature DB >> 11068587

[What do we know about the mechanisms of the time factor in oncological therapy?].

C Petersen1, M Baumann.   

Abstract

BACKGROUND: Experimental studies and prospective randomized clinical trials have demonstrated a detrimental effect of prolongation of overall treatment time on local tumor control.
METHODS: In a brief review of the literature, possible mechanisms of the time factor are discussed. RESULTS AND
CONCLUSIONS: The mechanisms of the time factor in cancer treatment are complex and, at present, not fully understood. In experimental tumors, rapid proliferation of clonogenic cells during fractionated irradiation and treatment gaps has been determined as a major cause of the time factor in radiotherapy. Also, chemotherapy can stimulate repopulation of experimental tumors by clonogenic cells. Besides repopulation of clonogenic tumor cells, other factors such as the deterioration of the tumor vasculature with increasing tumor hypoxia might contribute to the time factor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11068587     DOI: 10.1007/pl00002307

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  1 in total

1.  Survival benefit with radiation therapy in node-positive breast carcinoma patients.

Authors:  Mia Voordeckers; Vincent Vinh-Hung; Jan Lamote; Annette Bretz; Guy Storme
Journal:  Strahlenther Onkol       Date:  2009-10-06       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.